Clinical trial
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
NCT01890590 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 31, 2013
- Completion date
- March 31, 2025
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma